Jacobs Levy Equity Management’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-10,272
| Closed | -$254K | – | 1209 |
|
|
2016
Q2 | $254K | Buy |
10,272
+1,734
| +20% | +$42.9K | 0.01% | 935 |
|
|
2016
Q1 | $247K | Buy |
8,538
+6,725
| +371% | +$195K | 0.01% | 925 |
|
|
2015
Q4 | $67K | Sell |
1,813
-600
| -25% | -$22.2K | ﹤0.01% | 769 |
|
|
2015
Q3 | $118K | Sell |
2,413
-2,337
| -49% | -$114K | ﹤0.01% | 750 |
|
|
2015
Q2 | $328K | Sell |
4,750
-313
| -6% | -$21.6K | 0.01% | 634 |
|
|
2015
Q1 | $181K | Sell |
5,063
-787
| -13% | -$28.1K | ﹤0.01% | 713 |
|
|
2014
Q4 | $74K | Sell |
5,850
-4,880
| -45% | -$61.7K | ﹤0.01% | 792 |
|
|
2014
Q3 | $165K | Buy |
10,730
+9,000
| +520% | +$138K | ﹤0.01% | 768 |
|
|
2014
Q2 | $47K | Sell |
1,730
-95
| -5% | -$2.58K | ﹤0.01% | 815 |
|
|
2014
Q1 | $49K | Buy |
+1,825
| New | +$49K | ﹤0.01% | 871 |
|
|
2013
Q4 | – | Sell |
-4,408
| Closed | -$142K | – | 1084 |
|
|
2013
Q3 | $142K | Buy |
+4,408
| New | +$142K | ﹤0.01% | 878 |
|